MOLECULAR PHARMACOLOGY OF V-1A VASOPRESSIN RECEPTORS

被引:49
作者
HOWL, J
WHEATLEY, M
机构
来源
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 1995年 / 26卷 / 06期
基金
英国惠康基金;
关键词
VASOPRESSIN; OXYTOCIN; RECEPTOR; ANTAGONIST; PEPTIDE HORMONE;
D O I
10.1016/0306-3623(95)00016-T
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Vasopressin, a mammalian neurohypophysial peptide hormone, has diverse physiological actions. 2. Pharmacological studies, using a range of mammalian tissues, have identified three subtypes of vasopressin receptor. 3. The V-la subtype of vasopressin receptor is widely distributed and mediates many central and peripheral actions of vasopressin. 4. The development of subtype-selective vasopressin analogues has provided valuable tools for pharmacological and physical studies of the V-la receptor protein. 5. Pharmacological differences indicate species heterogeneity in the characteristics of V-la receptors and in the expression of hepatic V-la receptors. 6. The cloning of neurohypophysial hormone receptor proteins allows structural and functional comparison of the V-la vasopressin receptors with other G-protein-coupled receptors.
引用
收藏
页码:1143 / 1152
页数:10
相关论文
共 86 条
[11]   RAPID BREAKDOWN OF PHOSPHATIDYLINOSITOL 4-PHOSPHATE AND PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE IN RAT HEPATOCYTES STIMULATED BY VASOPRESSIN AND OTHER CA-2+-MOBILIZING HORMONES [J].
CREBA, JA ;
DOWNES, CP ;
HAWKINS, PT ;
BREWSTER, G ;
MICHELL, RH ;
KIRK, CJ .
BIOCHEMICAL JOURNAL, 1983, 212 (03) :733-747
[12]  
DASSO LLT, 1992, MOL PHARMACOL, V42, P453
[13]   CENTRAL TARGET FOR THE BEHAVIORAL-EFFECTS OF VASOPRESSIN NEUROPEPTIDES [J].
DEWIED, D ;
GAFFORI, O ;
VANREE, JM ;
DEJONG, W .
NATURE, 1984, 308 (5956) :276-278
[14]   ACTIONS OF NEUROHYPOPHYSEAL PEPTIDES ON PANCREATIC HORMONE-RELEASE [J].
DUNNING, BE ;
MOLTZ, JH ;
FAWCETT, CP .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (01) :E108-E114
[15]   I-125-D(CH2)5[TYR(ME)2,TYR(NH2)9]AVP - IODINATION AND BINDING CHARACTERISTICS OF A VASOPRESSIN RECEPTOR LIGAND [J].
ELANDS, J ;
BARBERIS, C ;
JARD, S ;
LAMMEK, B ;
MANNING, M ;
SAWYER, WH ;
DEKLOET, ER .
FEBS LETTERS, 1988, 229 (02) :251-255
[16]   EFFECT OF ANGIOTENSIN-II AND ARGININE VASOPRESSIN ON ALDOSTERONE PRODUCTION AND PHOSPHOINOSITIDE TURNOVER IN RAT ADRENAL GLOMERULOSA CELLS - A COMPARATIVE-STUDY [J].
ENYEDI, P ;
BALLA, T ;
ANTONI, FA ;
SPAT, A .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1988, 1 (02) :117-124
[17]   ARGININE VASOPRESSIN IS A MUCH MORE POTENT STIMULUS TO ACTH RELEASE FROM OVINE ANTERIOR-PITUITARY CELLS THAN OVINE CORTICOTROPIN-RELEASING FACTOR .1. INVITRO STUDIES [J].
FAMILARI, M ;
SMITH, AI ;
SMITH, R ;
FUNDER, JW .
NEUROENDOCRINOLOGY, 1989, 50 (02) :152-157
[18]   CORTICOTROPIN RELEASING ACTIVITY OF THE NEW CRF IS POTENTIATED SEVERAL TIMES BY VASOPRESSIN [J].
GILLIES, GE ;
LINTON, EA ;
LOWRY, PJ .
NATURE, 1982, 299 (5881) :355-357
[19]   CHARACTERIZATION OF SPECIFIC V1A VASOPRESSIN-BINDING SITES ON A RAT MAMMARY-TUMOR-CELL LINE [J].
GUILLON, G ;
KIRK, CJ ;
BALESTRE, MN .
BIOCHEMICAL JOURNAL, 1986, 240 (01) :189-196
[20]   ANTI-DIURETIC HORMONE [J].
HANDLER, JS ;
ORLOFF, J .
ANNUAL REVIEW OF PHYSIOLOGY, 1981, 43 :611-624